Rep. Maxine Dexter (D-Ore.) introduced the Dietary Supplement Listing Act of 2026 (H.R. 8370) on April 20, and it was referred to the House Energy and Commerce Committee, according to the official bill text. The proposal would require each supplement’s responsible company to list the product with the FDA, including its label, ingredients and form, such as tablets, capsules, powders, liquids or gummies. The FDA would then maintain a public, searchable database and issue each product a listing number to appear on its label.
Listings for products already on the market would be due 18 months after enactment, with label numbers required after two years. The bill states that it does not give the FDA authority to require approval before marketing. As reported by Nutritional Outlook, supporters say a registry would help regulators identify misbranded or adulterated products. The Council for Responsible Nutrition backs the measure, the Natural Products Association opposes it, and the American Herbal Products Association does not oppose listing in principle but wants changes to the label-number requirement. The bill remains a proposal.